Phase 1 Study Assessing the Safety and Tolerability of CTX-4430

NCT01748838 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Inflammation

Interventions

DRUG: CTX-4430
OTHER: Mannitol
DRUG: Placebo
DRUG: CTX-4430
DRUG: Placebo
OTHER: Mannitol

Sponsor

Celtaxsys, Inc.

Collaborators

[object Object]
[object Object]
[object Object]